Peptide Conjugates

Peptide Conjugates—Design, Link, Deliver

Peptide conjugation is emerging as a powerful approach for targeted drug delivery, offering a new modality to improve therapeutic precision. By linking peptides with functional molecules, this strategy can boost efficacy while minimizing off-target effects, particularly in oncology and other complex indications.

PeptAR_x integrates peptide chemistry with conjugation expertise to design and deliver targeted therapeutics and imaging agents—enhancing cellular uptake, half-life, and specificity for greater translational impact.

Our platform combines comprehensive peptide capabilities with advanced small-molecule chemistry, creating a one-stop solution for your peptide conjugate discovery and development needs. 

We support various peptide conjugates, including but not limited to:

• Peptide–Toxin / Drug (for targeted payload delivery)
• Peptide–Metal / DOTA-Derivatized (radiolabeling-ready scaffolds for imaging/therapy)
• Peptide–GalNAc / Lipid / PEG (hepatocyte targeting & pharmacokinetic tuning)
• Peptide–Oligonucleotide / PMO (PPMO) (dual modality engagement)
• Peptide-Protein Bioconjugates (site‑specific linkage for functional modulation)
• Fluorescent/Tagged Peptides (visualization & realtime tracking; demonstrated >1 g scale with >97% purity)